Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lonza Group Ltd ( (CH:LONN) ) has issued an announcement.
Lonza Group Ltd held its 2025 General Meeting, where all proposals by the Board of Directors were approved, including the re-election of Jean-Marc Huët as Chairman and the election of new board members. A dividend of CHF 4.00 per share will be distributed from May 15, 2025. Deloitte was re-elected as the auditor for 2026, and the shareholders supported all other proposals, including the compensation report and non-financial matters.
More about Lonza Group Ltd
Lonza is a leading contract development and manufacturing organization (CDMO) in the healthcare industry, collaborating with pharmaceutical and biotechnology companies to develop effective therapies. With a global presence on five continents and a workforce of around 18,500 employees, Lonza generated sales of CHF 6.6 billion and a core EBITDA of CHF 1.9 billion in 2024.
Average Trading Volume: 184,455
Current Market Cap: CHF40.63B
Learn more about LONN stock on TipRanks’ Stock Analysis page.